KBU2046
Catalog No. A18750
KBU2046 is an oral, highly selective inhibitor of cell motility and cell invasion in vitro. KBU2046 binds chaperone heterocomplexes, selectively alters binding of client proteins that regulate motility, and lacks all of the hallmarks of classical HSP90 inhibitors. KBU2046 inhibits cancer metastasis and prolongs life.
| Catalog Num | A18750 |
|---|---|
| M. Wt | 242.24 |
| Formula | C15H11FO2 |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 1143863-69-7 |
| Synonyms | KBU2046; KBU-2046; KBU 2046; |
| SMILES | O=C1C(C2=CC=C(F)C=C2)COC3=C1C=CC=C3 |
KBU2046 is an oral, highly selective inhibitor of cell motility and cell invasion in vitro. KBU2046 binds chaperone heterocomplexes, selectively alters binding of client proteins that regulate motility, and lacks all of the hallmarks of classical HSP90 inhibitors. KBU2046 inhibits cancer metastasis and prolongs life.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 41.28 mL | 206.41 mL | 412.81 mL |
| 0.5 mM | 8.26 mL | 41.28 mL | 82.56 mL |
| 1 mM | 4.13 mL | 20.64 mL | 41.28 mL |
| 5 mM | 0.83 mL | 4.13 mL | 8.26 mL |
*The above data is based on the productmolecular weight 242.24. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.